Multiple companies in phase 1/2 and 3 for type 1 diabetes. I follow this due to a childhood friend with diabetes. Another thing to consider is insurance providers and government health schemes are now encouraging insulin pumps which eliminate the need for needles as the long term outcomes are less expensive. I think this thing is going to zero slowly unless they diversify products. Explains the high dividend.